泌尿器科領域における新鎮痙鎮痛剤CG-201複合製剤の使用経験
スポンサーリンク
概要
- 論文の詳細を見る
A total of 84 patients who complained of pain due to various causes was treated with "Compound CG-201" at the Department of Urology of Hiroshima University Hospital. Clinical effectiveness of the drug was evaluated as follows. 1) The drug was effective in all cases of either oral or intravenous administration. 2) The time necessitated to have effect of the drug after administration was within 30 minutes for oral use and within 5 minutes for intravenous use. The duration of effectiveness was estimated to be more than 2 hours. 3) The drug was especially effective for renal colic and vesico-urethral pain, 4) No noticeable serious side effect including hepatic or renal functional disturbances was noted.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績